Enerplus Corp.

Enerplus Corp. (NYSE: ERF), relating to its proposed merger with Chord Energy Corp. Under the terms of the agreement, ERF shareholders are expected to receive 0.10125 shares of Chord plus $1.84 in cash per share they own.

Diamondback Energy, Inc.

Diamondback Energy, Inc. (Nasdaq: FANG), relating to its proposed merger with Endeavor Energy Resources L.P. Under the terms of the agreement, FANG shareholders are expected to own approximately 60.5% of the combined company.

CymaBay Therapeutics, Inc.

CymaBay Therapeutics, Inc. (Nasdaq: CBAY), relating to its proposed sale to Gilead Sciences, Inc. Under the terms of the agreement, CBAY shareholders will receive $32.50 in cash per share they own.

Assure Holdings Corp.

Assure Holdings Corp. (Nasdaq: IONM), relating to its proposed merger with Danam Health, Inc. Under the terms of the agreement, Assure shareholders are expected to own approximately 10% of the combined company.

ContextLogic, Inc.

ContextLogic, Inc. (Nasdaq: WISH), relating to its proposed sale to Qoo10. Under the terms of the agreement, WISH shareholders will receive $6.50 in cash per share they own.

Fresh Vine Wine Inc.

Fresh Vine Wine Inc. (NYSE: VINE), relating to its proposed sale to Notes Live, Inc.

McGrath RentCorp

McGrath RentCorp (Nasdaq: MGRC), relating to its proposed sale to WillScot Mobile Mini Holdings Corp. Under the terms of the agreement, MGRC shareholders will receive either $123.00 in cash or 2.8211 shares of WillScot per share they own.

California BanCorp

California BanCorp (NASDAQ: CALB), relating to its proposed merger with Southern California Bancorp. Under the terms of the agreement, California BanCorp shareholders will own approximately 42.9% of outstanding shares of the combined company.

AVROBIO, Inc.

AVROBIO, Inc. (Nasdaq: AVRO), relating to its proposed merger with Tectonic Therapeutic, Inc. Under the terms of the agreement, AVRO shareholders are expected to own approximately 22.3% of the combined company.

Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE), relating to its proposed sale to eMed, LLC. Under the terms of the agreement, SNCE shareholders will receive $5.75 in cash per share they own.